Skip to main content

Table 2 IVUS measurements

From: Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study

  NR group
(N = 81)
IR/PR group
(N = 62)
P value
Lesion site
 EEM CSA (mm2) 12.54 ± 4.39 16.50 ± 4.51 < 0.001
 Lumen CSA (mm2) 3.91 ± 1.73 4.08 ± 1.76 0.564
 P&M CSA (mm2) 8.63 ± 3.50 12.42 ± 4.04 < 0.001
 Plaque burden (%) 68.08 ± 10.04 74.71 ± 8.62 < 0.001
Eccentricity index 0.77 ± 0.20 0.74 ± 0.20 0.423
Eccentric lesion, n (%) 70 (86.4) 54 (87.1) 0.906
Proximal reference
 EEM CSA (mm2) 15.67 ± 4.67 15.63 ± 3.76 0.949
 Lumen CSA (mm2) 10.44 ± 3.62 9.75 ± 3.19 0.241
 P&M CSA (mm2) 5.31 ± 2.97 5.87 ± 2.67 0.245
 Plaque burden (%) 31.80 ± 16.39 35.88 ± 17.03 0.150
Distal reference
 EEM CSA (mm2) 14.32 ± 6.70 14.34 ± 4.76 0.983
 Lumen CSA (mm2) 9.07 ± 3.28 9.05 ± 4.06 0.983
 P&M CSA (mm2) 4.79 ± 3.65 5.29 ± 3.42 0.404
 Plaque burden (%) 31.81 ± 15.68 35.81 ± 19.52 0.176
Plaque composition
 Soft, n (%) 18 (22.2) 19 (32.3) 0.178
 Fibrous, n (%) 45 (55.6) 33 (53.2) 0.782
 Calcific (< 90°), n (%) 13 (16.0) 7 (11.3) 0.416
 Mixed, n (%) 5 (6.3) 3 (4.8) 0.718
  1. NR, negative remodeling; IR/PR, intermediate or positive remodeling; CSA, cross sectional area; P&M, Plaque and media; EEM, external elastic membrane